(2E)-3-(2,3-dimethoxyphenyl)-1-(4-methylphenyl)prop-2-en-1-one, 95.0%, 10g

1-chloro-5-iodo-4-methyl-2-nitrobenzene, 95.0%, 1g

4-Bromo-2-(difluoromethoxy)-6-methylpyridine, 97%, 1g

5-Fluoro-6-methylbenzo[d]thiazol-2-amine, 98%, 100mg

4-Bromo-3,7-dichloro-1H-indazole, 98%, 5g

ETHYL (1S,2R)-2-AMINOCYCLOHEXANE-1-CARBOXYLATE HCL, 95%, 250mg

5-Chloro-3-iodopyridin-2(1H)-one, 95.0%, 1g

4-(Methoxycarbonyl)tetrahydro-2H-pyran-4-carboxylic acid, 98%, 100mg

(S)-2-Amino-3-(4,4-difluorocyclohexyl)propanoic acid hydrochloride, 97%, 100mg

1,1,1,2,2,3,4,5,5,5-Decafluoro-3-methoxy-4-(trifluoromethyl)pentane>98.0%(GC)500g

4-BROMO-6-CHLORO-1H-INDOLE-3-CARBALDEHYDE, 95.0%, 250mg

PMPip BTA, 25 g, >=99%, glass packaging

(R)-4-(2,4-DIMETHOXYBENZYL)-3-METHYLPIPERAZIN-2-ONE HCL, 95.0%, 250mg